跳至主要内容
临床试验/IRCT201203192150N2
IRCT201203192150N2已完成2 期

Evaluation of the Effect of Citalopram on Three Months Functional Prognosis of Acute Ischemic Stroke Patients: A Randomized Clinical Trial

eurosciences Research Center0 个研究点目标入组 144 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 100 years(—)
性别
All

入选标准

  • 1- Acute ischemic stroke hospitalization in Razi university hospital; 2- No previous use of citalopram and other antidepressants, MAOI, Neuroleptic drugs and benzodiazepines in the last month before the onset of symptoms; 3- Not having a severe disability after stroke(NIHSS<20); 4-Not having Depression(MADRS>18). Exclusion criteria: 1- Request of patients to Exit from the study; 2- Previous chronic disease interferes with the performance evaluation in patients such as: chronic infections, liver or kidney failure, cancers; 3- Residual weakness of previous stroke; 4- Pregnancy or breastfeeding or any conditions that makes follow up impossible; 5- Sever loss of Consciousness; 6- Thrombolytic therapy; 7-Endarterectomy; 8- Depression(MADRS>18).

排除标准

  • 未提供

研究者

发起方
eurosciences Research Center

相似试验